A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka.


Journal

Environmental science and pollution research international
ISSN: 1614-7499
Titre abrégé: Environ Sci Pollut Res Int
Pays: Germany
ID NLM: 9441769

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 26 04 2018
accepted: 21 11 2018
pubmed: 1 12 2018
medline: 23 2 2019
entrez: 1 12 2018
Statut: ppublish

Résumé

Higher incidence of diabetes along with increased use of pesticides is seen in Southeast Asia. Recent hypothesis postulated a link between acetylcholinesterase inhibitor insecticides and type 2 diabetes through the GLP-1 pathway. This study compares the GLP-1 response between groups with low and high red blood cell acetylcholinesterase (RBC-AChE) activity. A comparative cross-sectional study was conducted amongst patients who were within 3 months after an acute organophosphate or carbamate poisoning (acute group) and amongst vegetable farmers with low (chronic group) and high (control group) RBC-AChE activity. Acute (366 mU/μM Hb) and chronic (361 mU/μM Hb) groups had significantly lower RBC-AChE activity in comparison to the control (471 mU/μM Hb) group (P < 0.0001). Only the acute group, which has had atropine therapy, showed a significantly lower 120 min value in comparison to the control group (P = 0.0028). Also, the acute group had significantly low late (P = 0.0287) and total (P = 0.0358) responses of GLP-1 in comparison to the control group. The findings of the study allude towards attenuation of GLP-1 response amongst patients after acute organophosphate and carbamate poisoning. The possibility of an atropine-mediated attenuation of GLP-1 response was discussed.

Identifiants

pubmed: 30499084
doi: 10.1007/s11356-018-3818-9
pii: 10.1007/s11356-018-3818-9
doi:

Substances chimiques

Carbamates 0
Incretins 0
Insecticides 0
Atropine 7C0697DR9I
Glucagon-Like Peptide 1 89750-14-1
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2864-2872

Subventions

Organisme : Research, Publication & Higher Degrees Committee, Rajarata University of Sri Lanka
ID : RJT/RP&HDC/2017/FMAS/R/01

Références

Toxicol Lett. 1998 Dec 28;102-103:649-52
pubmed: 10022329
Clin Chim Acta. 1999 Oct;288(1-2):73-90
pubmed: 10529460
Diabetes. 2001 Mar;50(3):609-13
pubmed: 11246881
Diabetes. 2001 May;50(5):1030-8
pubmed: 11334405
Endocrinology. 2002 Jun;143(6):2420-6
pubmed: 12021207
Pharmacol Biochem Behav. 2003 Mar;74(4):977-86
pubmed: 12667913
J Clin Endocrinol Metab. 1964 Oct;24:1076-82
pubmed: 14228531
Acta Clin Belg. 2003 Nov-Dec;58(6):335-41
pubmed: 15068125
Physiol Rev. 2007 Oct;87(4):1409-39
pubmed: 17928588
Am J Epidemiol. 2008 May 15;167(10):1235-46
pubmed: 18343878
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
JAMA. 2009 May 27;301(20):2129-40
pubmed: 19470990
Hum Exp Toxicol. 2011 Sep;30(9):1119-40
pubmed: 21071550
Diabetologia. 2011 Jun;54(6):1273-90
pubmed: 21442161
Environ Health Perspect. 1990 Jul;87:245-54
pubmed: 2176588
Environ Health Perspect. 2012 Jun;120(6):779-89
pubmed: 22296744
J Physiol. 2012 Jun 15;590(12):2917-36
pubmed: 22495587
BMC Public Health. 2012 Aug 02;12:593
pubmed: 22852867
Diabetologia. 2013 Apr;56(4):696-708
pubmed: 23344728
J Clin Endocrinol Metab. 2014 Jul;99(7):2457-66
pubmed: 24712563
Toxicology. 2014 Aug 1;322:1-13
pubmed: 24801903
J Diabetes Investig. 2010 Apr 22;1(1-2):8-23
pubmed: 24843404
Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):30-8
pubmed: 25593823
J Diabetes Complications. 2015 Apr;29(3):445-50
pubmed: 25623632
Diabetes. 2015 Jul;64(7):2513-25
pubmed: 25677912
Lancet Diabetes Endocrinol. 2015 Dec;3(12):925-7
pubmed: 26575608
Med Hypotheses. 2016 Jun;91:53-55
pubmed: 27142144
BMC Health Serv Res. 2017 Jan 5;17(1):11
pubmed: 28056960
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Diabetologia. 1986 Jan;29(1):46-52
pubmed: 3514343
J Clin Invest. 1967 Dec;46(12):1954-62
pubmed: 6074000
J Endocrinol. 1995 Oct;147(1):25-31
pubmed: 7490533
J Clin Endocrinol Metab. 1997 Mar;82(3):786-90
pubmed: 9062483

Auteurs

Devarajan Rathish (D)

Department of Pharmacology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka. rathishdeva@gmail.com.

Indika Senavirathna (I)

Department of Biochemistry, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.

Channa Jayasumana (C)

Department of Pharmacology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.

Suneth Agampodi (S)

Department of Community Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.

Sisira Siribaddana (S)

Department of Medicine, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH